about
Translation, adaptation, validation and performance of the American Weight Efficacy Lifestyle Questionnaire Short Form (WEL-SF) to a Norwegian version: a cross-sectional study.An exploratory investigation of links between changes in adipokines and quality of life in individuals undergoing weight loss interventions: possible implications for cancer research.Health related quality of life after gastric bypass or intensive lifestyle intervention: a controlled clinical study.Predictors of weight loss after an intensive lifestyle intervention program in obese patients: a 1-year prospective cohort studyThe relationship between emotional regulation and eating behaviour: a multidimensional analysis of obesity psychopathology.Mental and physical health-related quality of life in obese patients before and after bariatric surgery: a meta-analysis.Five-Year Outcomes After Vertical Sleeve Gastrectomy for Severe Obesity: A Prospective Cohort Study.Characteristics of suicidal outpatients with mood, anxiety and somatoform disorders: The role of childhood abuse and neglect.Chronic Abdominal Pain and Symptoms 5 Years After Gastric Bypass for Morbid Obesity.The effectiveness of secondary and tertiary care lifestyle intervention in morbidly obese patients: a 1-year non-randomized controlled pragmatic clinical trial.Changes in Health-Related Quality of Life After Gastric Bypass in Patients With and Without Obesity-Related Disease.Beyond weight reduction: improvements in quality of life after an intensive lifestyle intervention in subjects with severe obesity.Validity of standard gamble utilities in patients referred for aortic valve replacement.Obese Adolescents Report Better Health-Related Quality of Life than Obese Young Adults.Functional Evaluation (Joint and Muscle Problems, Cardiopulmonary Exercise Testing, Disability Evaluation)
P2860
Q34260165-DD455A51-8D93-42A2-90DC-A27CCD2BBE4AQ35121916-D9E490CD-FE7D-4A28-AE1A-6C84B532D51CQ36690289-F9CF5B47-CF09-4A61-B498-7D81D8122447Q37364107-03484511-44BF-44FF-B249-102BAC61B13BQ37678029-2D3B44C1-AF45-4498-B8E5-E306D91D388BQ38254536-A34CD2D4-7F80-4317-ACCF-F843032BC4FEQ38948749-E39DDB66-D874-4A85-912A-1CD00C50DCA5Q39983234-B6CB2737-F489-476C-A770-9B4A73D77D70Q40405312-6F4CABD4-B3F6-442A-B416-199E896E43B0Q41586246-1137C023-C1B1-416A-BDD4-BD4BCFC9DB04Q41720933-B7BA08B4-2AE2-4C94-B787-7EBFFED81482Q47185341-2AFF027C-F687-481F-9673-9E81510CF590Q47901063-53B42B37-D838-490F-8E01-6971A660BB62Q48040298-C4BD9A48-1084-4BB3-8085-62A7FCF5EC32Q59161366-98C52E5B-2CA9-4228-B437-D6F14DBBD483
P2860
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Validity of the SF-36 in patients with morbid obesity.
@en
Validity of the SF-36 in patients with morbid obesity.
@nl
type
label
Validity of the SF-36 in patients with morbid obesity.
@en
Validity of the SF-36 in patients with morbid obesity.
@nl
prefLabel
Validity of the SF-36 in patients with morbid obesity.
@en
Validity of the SF-36 in patients with morbid obesity.
@nl
P2093
P2860
P356
P1433
P1476
Validity of the SF-36 in patients with morbid obesity
@en
P2093
Einar K Tveitå
Gerd K Natvig
Jøran Hjelmesæth
Serena Tonstad
Tor-Ivar Karlsen
P2860
P304
P356
10.1159/000333406
P577
2011-10-21T00:00:00Z